Literature DB >> 16078235

Macrophage-induced inflammation affects hippocampal plasticity and neuronal development in a murine model of HIV-1 encephalitis.

Larisa Poluektova1, Vakara Meyer, Lisa Walters, Ximena Paez, Howard E Gendelman.   

Abstract

Cognitive, behavioral, and motor impairments, during progressive human immunodeficiency virus type 1 (HIV-1) infection, are linked to activation of brain mononuclear phagocytes (MP; perivascular macrophages and microglia). Activated MPs effect a giant cell encephalitis and neuroinflammatory responses that are mirrored in severe combined immunodeficient (SCID) mice injected with human monocyte-derived macrophages (MDM). Whether activated human MDMs positioned in the basal ganglia affect hippocampal neuronal plasticity, the brain subregion involved in learning and memory, is unknown. Thus, immunohistochemical techniques were used for detection of newborn neurons (polysialylated neuronal cell adhesion molecule [PSA-NCAM]) and cell proliferation (Ki-67) to assay MDM effects on neuronal development in mouse models of HIV-1 encephalitis. Immunodeficient (C.B.-17/SCID and nonobese diabetic/SCID, NOD/SCID) and immune competent (C.B.-17) mice were injected with uninfected or HIV-1-infected MDM. Sham-operated or unmanipulated mice served as controls. Neuronal plasticity was evaluated in the hippocampal dentate gyrus (DG) at days 7 and 28. By day 7, increased numbers of Ki-67+ cells, PSA-NCAM+ cells and dendrites in DG were observed in sham-operated animals. In contrast, significant reductions in neuronal precursors and altered neuronal morphology paralleled increased microglial activation in both HIV-1-infected and uninfected MDM-injected animals. DG cellular composition was restored at day 28. We posit that activated MDM induce inflammation and diminish DG neuronal plasticity. These data provide novel explanations for the cognitive impairments manifested during advanced HIV-1 infection. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16078235     DOI: 10.1002/glia.20253

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  31 in total

Review 1.  Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury.

Authors:  Ricky Maung; Kathryn E Medders; Natalia E Sejbuk; Maya K Desai; Rossella Russo; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-29       Impact factor: 4.147

2.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 3.  Rodent models for HIV-associated neurocognitive disorders.

Authors:  Santhi Gorantla; Larisa Poluektova; Howard E Gendelman
Journal:  Trends Neurosci       Date:  2012-02-01       Impact factor: 13.837

4.  Tissue expression of steroid hormone receptors is associated with differential immune responsiveness.

Authors:  Cherié L Butts; Yava L Jones; Jean K Lim; Caroline E Salter; Elena Belyavskaya; Esther M Sternberg
Journal:  Brain Behav Immun       Date:  2010-11-11       Impact factor: 7.217

Review 5.  Mitogen-activated protein kinase p38 in HIV infection and associated brain injury.

Authors:  Kathryn E Medders; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-01       Impact factor: 4.147

6.  Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders.

Authors:  Ruma Mukerjee; J Robert Chang; Luis Del Valle; Asen Bagashev; Monika M Gayed; Randolph B Lyde; Brian J Hawkins; Eugen Brailoiu; Eric Cohen; Chris Power; S Ausim Azizi; Benjamin B Gelman; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

Review 7.  Doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) as an HIV/neuroAIDS model.

Authors:  Dianne Langford; Byung Oh Kim; Wei Zou; Yan Fan; Pejman Rahimain; Ying Liu; Johnny J He
Journal:  J Neurovirol       Date:  2017-11-15       Impact factor: 2.643

8.  The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.

Authors:  Randall L Davis; Daniel J Buck; Neda Saffarian; Craig W Stevens
Journal:  J Neuroimmunol       Date:  2007-05-01       Impact factor: 3.478

9.  HIV-1-infected and/or immune-activated macrophage-secreted TNF-alpha affects human fetal cortical neural progenitor cell proliferation and differentiation.

Authors:  Hui Peng; Nicholas Whitney; Yumei Wu; Changhai Tian; Huanyu Dou; You Zhou; Jialin Zheng
Journal:  Glia       Date:  2008-06       Impact factor: 7.452

10.  Beta-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells.

Authors:  Randall L Davis; Daniel J Buck; Neda Saffarian; Shekher Mohan; Udaya DeSilva; Samodha C Fernando; Craig W Stevens
Journal:  J Neuroimmune Pharmacol       Date:  2008-02-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.